ÂÜÀòÂÒÂ×

Matthew Frohn is the current Director at Biofidelity. Prior to that, they were the Director at Oxford Technology Management from June 1999 to November 2012. OTM makes and manages venture capital investments in early stage technology companies.

Matthew Frohn has a D.Phil in Biochemistry from the University of Oxford and a Bachelor's Degree in Cell & Molecular Biology from Oxford Brookes University.